Search - tctmd.com

Displaying 101 - 120 of 165

Sort: Relevancy | Date

Presentation TCT 2020

TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease

Presenter: Brian Forrestal

October 14, 2020

Presentation TCT 2020

TCT 375: Gender Differences on the Rate of Success of Percutaneous Lower Limb Arteries Revascularization

Presenter: Carlos Giuliani

October 14, 2020

Presentation TCT 2020

TCT 050: Percutaneous Coronary Intervention Outcomes in Women With Spontaneous Coronary Artery Dissection: A Propensity Matched Analysis

Presenter: Padma Shenoy

October 14, 2020

News Opinion Editor's Corner TCT 2020

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

Shelley Wood

October 09, 2020

News Conference News TCT 2019

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

L.A. McKeown

October 04, 2019

Presentation TCT 2019

Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration

Presenter: Robert Byrne

September 28, 2019

News Conference News TCT 2019

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

Presenter: Sreekala Padmanabhan

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

News Conference News TCT 2019

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

L.A. McKeown

September 28, 2019

Presentation TCT 2019

Perspective: The Case for Ongoing Use of Drug-Eluting Technologies for PAD

Presenter: William Gray

September 27, 2019

Presentation TCT 2019

Perspective: The Case Against Ongoing Use of Drug-Eluting Technologies for PAD

Presenter: Konstantinos Katsanos

September 27, 2019

Presentation TCT 2019

Safety of PTX Devices for PAD in Japan: Academic View

Presenter: Masato Nakamura

September 26, 2019

Presentation TCT 2019

Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data

Presenter: Roseann White

September 26, 2019

Presentation TCT 2019

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

Presenter: Eleni Whatley

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

TCT Shark Tank Innovation Competition Finalists - Transcatheter Cardiac Leaflet Enhancer (CARLEN) for Functional Mitral and Tricuspid Regurgitation (Nyra Medical)

Presentation TCT 2019

Transcatheter Cardiac Leaflet Enhancer (CARLEN) for Functional Mitral and Tricuspid Regurgitation (Nyra Medical)

Presenter: Muralidhar Padala

September 26, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

Presentation TCT 2018

PAD: Overview of Current Management Strategies - Can We Do Better?

Presenter: Wayne B. Batchelor, Aaron Horne, Jr., Foluso Fakorede

September 24, 2018

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

Advertisement

TCT 370: A Patient-Level, Pooled Analysis of Mortality Rates With the Passeo-18 Lux Paclitaxel Drug-Coated Balloon in Peripheral Arterial Disease

TCT 375: Gender Differences on the Rate of Success of Percutaneous Lower Limb Arteries Revascularization

TCT 050: Percutaneous Coronary Intervention Outcomes in Women With Spontaneous Coronary Artery Dissection: A Propensity Matched Analysis

TCT 2020: Short DAPT, Longer TAVR Outcomes, Intravascular Imaging, and More

PICCOLETO II: More Support for DCB Safety and Efficacy in Small Coronaries

Paclitaxel-Coated Balloons for Coronary Intervention: Critical Review of Long-Term Trial Data in Light of the PAD Controversy — The DAEDALUS Collaboration

LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD

Case: Critical Limb Ischemia Treated by Infrapopliteal DEB

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures

Perspective: The Case for Ongoing Use of Drug-Eluting Technologies for PAD

Perspective: The Case Against Ongoing Use of Drug-Eluting Technologies for PAD

Safety of PTX Devices for PAD in Japan: Academic View

Statistical Considerations: Competing Risk, Pooling Data, RCT vs. Observational Data

Moving From “Signal Detection” to “Signal Discernment”: An FDA View

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Transcatheter Cardiac Leaflet Enhancer (CARLEN) for Functional Mitral and Tricuspid Regurgitation (Nyra Medical)

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

PAD: Overview of Current Management Strategies - Can We Do Better?

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content